How can the market react negatively when the market isn't even pricing in a MAP price at the base case of the scoping study??????
The MAP price is currently around double the mid point of their base case range of $357 - $482.
Clearly the market is nowhere near pricing in current prices (NPV would be over $700mill). How much of a discount can they give?
Ann: Agreement signed as early work underway on Cabinda Project, page-24
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
